In addition, we analyzed formalin fixed paraffin embedded (FFPE) breast tumor specimens from BRCA1/2 mutation carriers and found relatively high methylation levels (nearly 80%) at the deltaNp73 promoter (P2) in all tumors, regardless of their subtype (Figure 7C). This evidence concerns the gene BRCA1 and breast neoplasm.